Skip to main content
. 2018 Jan 5;18:7. doi: 10.1186/s12905-017-0507-7

Table 3.

EORTC QLQ-C30 functional scores by socio-demographic and clinical characteristics of gynaecological cancer patients at TASH Addis Ababa, Ethiopia, (n = 140)

Variables GHS Physical function Emotional function Role function Social function Cognitive function
Stage of the diseases Stage 1 54.86(±26.46 82.78(18.52 62.50(±30.26) 66.67(±34.82 48.61(±35.15 93.06(±16.60)
Stage 2 44.90(±20.04) 67.35(±19.59) 59.86(±28.29) 54.42(±34.66) 45.92(±33.34) 90.82(±13.64)
Stage 3 and 4 34.39(±24.32) 56.96(±24.44) 48.79(±31.07) 38.79(±34.99) 33.03(±29.48) 84.24(±21.85)
P-value 0.005* 0.002* 0.149 0.032* 0.065 <0.001*
Address Addis Ababa 45.09(26.47) 67.35(22.21) 58.76(±29.7) 53.42(±32.03) 51.71(±34.5) 88.89(15.45)
Out of Addis Ababa 39.36(23.42) 64.42(22.79) 54.21(30.59) 48.85(36.31) 38.61(30.45) 87.95(19.59)
P value 0.231 0.49 0.43 0.49 0.03* 0.79
Marital status Currently on marriage 39.41 ± (24.76) 62.16(±22.51) 50.45(±32.81) 46.85(±36.04) 41.67(±32.55) 85.81(±20.21)
Currently not on marriage 42.68(±23.95) 68.69(±22.34) 61.11(±26.3) 53.79(±33.94) 42.93(±31.77) 90.91(± 16.06)
P value 0.431 0.088 0.037* 0.244 0.817 0.104
Educational status Never go to school 36.55(±23.52 61.53(±23.51) 52.17(±29.2) 43.40(±34.92) 35.42(±30.6) 86.46(19.84)
Primary 48.26(±22.92) 74.44(±15.44) 63.54(±31.) 65.28(±31.82) 56.25(±33.27) 93.06(±13.83)
Secondary 54.55(±19.49) 70.91(±21.35) 62.88(±29.7) 60.61(±30.07) 54.55(30.81) 93.94(±11.24)
12+ 51.85(±31.12) 73.33(±22.61) 60.19(±31.39) 68.52(±33.79) 62.96(±23.24) 87.04(±20.03)
P value 0.013* 0.036* 0.296 0.008* 0.002* 0.310
Payment type Free 40.77(±27.55) 60.00(±24.39) 47.52(±33.90) 38.74(±38.90) 38.29(±37.03) 85.14(±18.75)
paying 41.02(±23.24) 67.12(±21.72) 58.33(±28.56) 54.21(±32.90) 43.69(±30.17) 89.32(±18.36)
P value 0.957 0.100 0.063 0.021* 0.382 0.239
Care givers relation suppose 43.00(±24.62) 71.73(±20.93) 53.00(±33.15) 59.33(±34.05) 48.00(±30.18) 93.33(±12.73)
parents 55.56(±27.0) 68.89(±26.04) 60.19(±20.32) 57.41(±36.4) 53.70(±30.93) 94.44(±11.79)
children 38.98(±23.39) 62.78(±22.01) 54.86(±31.13) 46.18(±34.67) 38.02(±32.3) 86.63(±20.03)
sibling 41.67(±29.13) 69.33(±27.97) 63.33(±23.64) 58.33(±39.48) 58.33(±29.66) 85.00(±18.34)
P value 0.257 0.289 0.782 0.278 0.104 0.269
Occupation Farmer 46.86(±26.51) 72.50(±23.71) 56.77(±30.61) 54.17(±43.67) 44.79(±33.73) 90.62 (±20.16)
Self employed 45.83(±17.63) 68.33(±18.08) 52.50(±29.01) 50.83(±32.21) 47.50(±30.24) 89.17(±18.16)
House wife 37.16(±23.32) 61.23(±22.43) 54.41(±30.97) 45.98(±34.19) 36.59(±31.22) 86.59(±18.82)
Government employ 51.39(±30.33) 76.11(±19.38) 57.64(±30.87) 66.67(±29.30) 58.33(±27.98) 93.06(±16.60)
Others (retired and employed) 43.33(±36.99) 73.33(±34.32) 76.67(±23.13) 66.67(±40.83) 73.33(±34.55) 93.33(±14.91)
P value 0.191 0.082 0.592 0.268 0.024* 0.704
Cancer type Cervical, vaginal, vulval 40.10(±24.01) 63.57(±23.35) 54.09(±30.33) 47.77(±36.11) 39.44(±31.08) 87.20(±19.76)
Ovarian 38.49(±19.98) 66.67(±14.76) 53.57(±28.45) 50.79(±20.74) 42.86(±29.61) 92.06(±12.49)
Endometrial 61.90(±34.65) 87.62(±19.02) 83.33(±25.00) 85.71(±37.80) 85.71(±26.23) 92.86(±8.91)
P value 0.062 0.022* 0.043* 0.020* 0.001* 0.433
Age < 40 years 35.18(±24.35) 64.44(±22.75) 46.30(±27.30) 49.08(±31.5) 36.11(±29.29) 87.96(±155.97)
40-49 years 42.82(±24.73) 68.15(±20.48) 52.08(±30.37) 50.00(±35.41) 43.52(±30.93) 86.11(±18.04)
50-59 years 39.68(±23.91) 63.97 (±22.48) 55.16 (±28.21) 49.21(±36.97) 36.91(±32.41) 89.68 (±18.01)
60-69 years 43.33(±23.81) 61.82 (±23.45) 59.00 (±32.80) 53.33(±36.00) 45.33(±32.82) 90.00 (±19.84)
P-value 0.89 0.52 0.079 0.98 0.72 0.73
Parity 0 59.701(±17.01) 85.56(±12.94) 62.50(±13.69) 63.89(±22.15) 63(22.15) 97.22(±6.81)
1-4 45.74(±25.65) 67.80(±24.01) 61.17(±29.09) 57.44(±33.66) 51.42(±34.01) 87.58(±17.88)
5-9 36.78(±23.11) 61.33(±21.40) 48.69(±30.05) 43.81(±36.14) 35.24(±29.29) 86.91(20.24)
≥10 36.79(±23.11) 61.33(±21.40) 48.69(±30.05) 43.81(±36.14) 35.24(±29.29) 86.90(±20.24)
P -value 0.052 0.052 0.063 0.16 0.016 0.46

t test (for two groups comparison) and one way ANOVA (for three and above group comparison) were employed,* significant at p-value less than 0.05